NCT02787486.

Trial name or title	Expanded Noninvasive Genomic Medical Assessment: the Enigma study.
Target condition and reference standard(s)	Target conditions: T21, T18, T13, microdeletion syndromes, sex chromosome abnormalities, infectious and other diseases, and blood group typing. Reference standard: fetal karyotype or medical records.
Index and comparator tests	gNIPT by MPSS provided by Progenity, Inc.
Starting date	October 2015.
Contact information	Paul Bien 760‐494‐1743 paul.bien@progenity.com
Aim to study	To evaluate the relative clinical sensitivity, specificity, and performance of the laboratory‐developed test as a screening test for fetal chromosomal aneuploidy, infectious and other diseases, and RhD genotyping in the general population of pregnant women.
Funding source or sponsor of the study	Study funded by Progenity, Inc.
Information about the authors contacted	No need for further contact.
Notes